These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 14058225)
1. A COMPARATIVE STUDY OF CLINICAL REACTION OBSERVED AFTER APPLICATION OF SEVERAL SMALLPOX VACCINES IN PRIMARY VACCINATION OF YOUNG ADULTS. POLAK MF; BEUNDERS BJ; VAN DER WERFF AR; SANDERS EW; VAN KLAVEREN J; BRANS LM Bull World Health Organ; 1963; 29(3):311-22. PubMed ID: 14058225 [TBL] [Abstract][Full Text] [Related]
2. Relationship between pock counts on chorio-allantoic membrane and percentages of "takes" in primary vaccination of human beings with two smallpox vaccines. POLAK MF; BRANS LM; BEUNDERSB J; van der WERFF A Bull World Health Organ; 1962; 27(3):311-6. PubMed ID: 13944288 [TBL] [Abstract][Full Text] [Related]
3. [Smallpox vaccine, then and now. From the "cow lymphe" to the cell-culture vaccine]. Hochstein-Mintzel V Fortschr Med; 1977 Jan; 95(2):79-84. PubMed ID: 13033 [TBL] [Abstract][Full Text] [Related]
4. [Development of a numerically additive combined vaccine against tetanus and smallpox]. Mayr A; Baljer G; Wagner C; Sailer J Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123 [TBL] [Abstract][Full Text] [Related]
6. Laboratory and vaccination studies with dried smallpox vaccines. COCKBURN WC; CROSS RM; DOWNIE AW; DUMBELL KR; KAPLAN C; MCCLEAN D; PAYNE AM Bull World Health Organ; 1957; 16(1):63-77. PubMed ID: 13413647 [TBL] [Abstract][Full Text] [Related]
7. [MVA-vaccine in primovaccination against smallpox after the age of three (author's transl)]. Schröter W; Stickl H; Idel H; Schlipköter HW Zentralbl Bakteriol Mikrobiol Hyg B; 1980 Sep; 171(4-5):309-19. PubMed ID: 7456853 [TBL] [Abstract][Full Text] [Related]
8. Mouse neurotoxicity test for vaccinia-based smallpox vaccines. Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573 [TBL] [Abstract][Full Text] [Related]
9. Ocular complications in the Department of Defense Smallpox Vaccination Program. Fillmore GL; Ward TP; Bower KS; Dudenhoefer EJ; Grabenstein JD; Berry GK; Madigan WP Ophthalmology; 2004 Nov; 111(11):2086-93. PubMed ID: 15522376 [TBL] [Abstract][Full Text] [Related]
10. Efficiency of smallpox revaccination repeated at three-year intervals. II. Comparative study of the international reference strain (Elstree) and the Hungarian vaccine strain (Budapest). Nyerges G; Hollós I; Losonczy G Acta Microbiol Acad Sci Hung; 1968; 15(3):187-97. PubMed ID: 5720872 [No Abstract] [Full Text] [Related]
11. Comparative efficacy of replicating smallpox vaccine strains in a murine challenge model. Phelps A; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO Vaccine; 2005 May; 23(27):3500-7. PubMed ID: 15855008 [TBL] [Abstract][Full Text] [Related]
12. Absence of oropharyngeal vaccinia virus after vaccinia (smallpox) vaccination. Klote MM; Ludwig GV; Ulrich MP; Black LA; Hack DC; Engler RJ; Martin BL Ann Allergy Asthma Immunol; 2005 Jun; 94(6):682-5. PubMed ID: 15984602 [TBL] [Abstract][Full Text] [Related]
13. [Primary vaccination against smallpox after preliminary vaccination with the attenuated vaccinia virus strain MVA and the use of a new "vaccination stamp"]. Stickl H; Hochstein-Mintzel V; Huber HC Munch Med Wochenschr; 1973 Aug; 115(35):1471-3. PubMed ID: 4740817 [No Abstract] [Full Text] [Related]
14. [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)]. Stickl H; Hochstein-Mintzel V; Mayr A; Huber HC; Schäfer H; Holzner A Dtsch Med Wochenschr; 1974 Nov; 99(47):2386-92. PubMed ID: 4426258 [No Abstract] [Full Text] [Related]
15. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model. Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917 [TBL] [Abstract][Full Text] [Related]
16. The immunogenetics of smallpox vaccination. Stanley SL; Frey SE; Taillon-Miller P; Guo J; Miller RD; Koboldt DC; Elashoff M; Christensen R; Saccone NL; Belshe RB J Infect Dis; 2007 Jul; 196(2):212-9. PubMed ID: 17570108 [TBL] [Abstract][Full Text] [Related]
17. Adverse events following smallpox vaccination with ACAM2000 in a military population. Beachkofsky TM; Carrizales SC; Bidinger JJ; Hrncir DE; Whittemore DE; Hivnor CM Arch Dermatol; 2010 Jun; 146(6):656-61. PubMed ID: 20566929 [TBL] [Abstract][Full Text] [Related]
18. The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks. Handley L; Buller RM; Frey SE; Bellone C; Parker S Expert Rev Vaccines; 2009 Jul; 8(7):841-50. PubMed ID: 19538111 [TBL] [Abstract][Full Text] [Related]
19. Comparative studies of smallpox vaccination by the bifurcated needle and rotary lancet techniques. Pattanayak S; Arora DD; Sehgal CL; Raghavan NG; Topa PK; Subrahmanyam YK Bull World Health Organ; 1970; 42(2):305-10. PubMed ID: 5310142 [TBL] [Abstract][Full Text] [Related]
20. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox. Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]